***Note: If contact is determined to have a fever ≥100.4° F, immediately call EOC at 770.488.7100.
Date of initial interview: ______/_____/______ Interviewed by: ____________________________________
Last Name: __________________ First Name: ______________________ Age:_____________
Sex: ____ Country of Birth: __________________ Country of Residence: ________________________
Travel Plans through insert date: ________________________________________________________
Street Address: ______________________________________________________ State: __________
Phone numbers- Home: _________________ Cell:__________________ Work:___________________
Circle flight(s) interviewee was on: [Complete flight information]
[Complete second flight information]
Assigned seat number: _________________ Did interviewee move to a different seat? Yes No
If yes, which seat did interviewee move to? ___________ Document time in each seat: _____________ ___________________________________________________________________________________
Did interviewee have any interactions with sick passengers from this flight(s)? Yes No
If yes, describe this event including location, degree of contact (talking with or touching) and length of time:_______________________________________________________________________________
Did interviewee have direct contact with body fluids of any passengers during the flight(s) circled above? Yes No (If no, skip to question 4)
If yes, describe the contact including location of the body fluid and any other individuals involved: _____
___________________________________________________________________________________
If yes, which body fluids did interviewee come into contact with? (Check all that apply)
Tears Saliva Respiratory secretions (cough and sneeze droplets)
Vomit Urine Blood Stool Sweat
If yes, did these fluids come in contact with the interviewee’s:
Intact skin
Broken skin (fresh cut or scratch which bled within 24 hours before the contact; burn or abrasion that had not dried)
Mucous membrane contact (eyes, nose or mouth)
Other (Specify): _________________________________________________________
__________________________________________________________________________________
Were there any incidents during or after the flight(s) that the interviewee can recall when other individuals were in contact with a person’s blood and/or body fluids?
Yes No
If yes, please describe situation and location in the plane and/or airport: ______________________
_______________________________________________________________________________
Please check all symptoms interviewee has had since flight:
Fever ≥100.4° F Sore throat Body aches/muscle pain Headache
Abdominal pain Vomiting Diarrhea Weakness
Rash Hiccups Unusual bleeding (e.g. from gums, eyes or nose)
Has interviewee travelled in any of the following countries within the last 21 days (check all that apply)? Sierra Leone Guinea Liberia Other
If any of the above countries are selected, please notify CDC by calling EOC. Contact will need to complete additional brief interview with CDC SME involving in-country exposure risk.
__________________________________________________________________________________
Classification of interviewee risk (Consult the CDC to classify each contact after interview. Refer to http://www.cdc.gov/vhf/ebola/hcp/case-definition.html for additional information):
High Risk: The index case’s body fluids came in contact with the interviewee’s bare skin (intact or
broken) or mucous membranes (eyes, mouth, nose).
Some Risk: Interviewee had close contact* with the index case but not body fluids; or was only exposed on protected areas of the body (e.g. on hands while wearing gloves).
No Known Risk**: Interviewee did not have any some risk or high risk exposures listed above.
Follow-up Actions:
Ebola information distributed
Fever watch: For all contacts regardless of classification of risk, provide fever watch form that should be reviewed by health department at least weekly.
Referred for medical evaluation due to presence of symptoms. If yes,
Where was (s)he referred? _________________________________________________________
What was the outcome? ___________________________________________________________
Declined medical evaluation after it was recommended
Was interviewee placed under conditional release? Yes No
Was interviewee placed under state issued quarantine order? Yes No
Final Disposition:
Was interviewee contacted again after [Fill in the date of the last day of the incubation period]?
Yes, Date of second interview: ______/_____/______ No
If yes, did interviewee develop any symptoms of Ebola between the time of flight and [Fill in date]? Yes No
If yes, please describe the symptoms, timing, and outcome of medical evaluation below: __________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
______________________________________________________________________________________
Evaluating healthcare provider name/phone number: __________________________/(____)____________
* Close contact is defined as a) being within approximately 3 feet (1 meter) or within the room or care area for a prolonged period of time (e.g., healthcare personnel, household members) while not wearing recommended personal protective equipment (i.e., droplet and contact precautions–see Infection Prevention and Control Recommendations); or b) having direct brief contact (e.g., shaking hands) with an EVD case while not wearing recommended personal protective equipment (i.e., droplet and contact precautions–see Infection Prevention and Control Recommendations). At this time, brief interactions, such as walking by a person or moving through a hospital, do not constitute close contact.
**No known risk may include passengers who were seated within 3 feet of the passenger for only a short amount of time.
Page
File Type | application/msword |
Author | CDC User |
Last Modified By | ije7 |
File Modified | 2014-10-15 |
File Created | 2014-10-15 |